Chapter 1. Biotransformations in Small-Molecule Pharmaceutical Development
- John Whittall3,
- Peter Sutton4
Published Online: 15 DEC 2009
DOI: 10.1002/9780470748589.ch1
Copyright © 2010 John Wiley & Sons, Ltd
Book Title

Practical Methods for Biocatalysis and Biotransformations
Additional Information
How to Cite
Adams, J. P., Collis, A. J., Henderson, R. K. and Sutton, P. W. (2009) Biotransformations in Small-Molecule Pharmaceutical Development, in Practical Methods for Biocatalysis and Biotransformations (eds J. Whittall and P. Sutton), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470748589.ch1
Editor Information
- 3
Manchester Interdisciplinary Biocentre, University of Manchester, United Kingdom
- 4
GlaxoSmithKline, Synthetic Chemistry, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
Publication History
- Published Online: 15 DEC 2009
- Published Print: 18 DEC 2009
ISBN Information
Print ISBN: 9780470519271
Online ISBN: 9780470748589
- Summary
- Chapter
- References
Keywords:
- biotransformations in small-molecule pharmaceutical development;
- new molecular entities (NMEs) and biologics, reaching the markets;
- active pharmaceutical ingredient (API);
- biocatalysis - current status;
- sparse incorporation of biocatalysts into process chemist's toolbox;
- application of biocatalysis in pharmaceutical industry;
- uridine diphosphate glucuronide transferase cycle;
- N-acetyl-D-neuraminic acid (NANA) - synthesized using NANA aldolase;
- enzyme immobilization - enzymatic DKR of thioester intermediate of odanacatib;
- Green Chemistry - use of biocatalysis in APIs manufacture
Summary
This chapter contains sections titled:
Introduction
Current Status of Biocatalysis
Application of Biocatalysis in the Pharmaceutical Industry
Enzymes in Organic Solvent
Enzyme Immobilization
Green Chemistry
Future Perspectives
Concluding Remarks
Acknowledgements
References
